Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-8554 in postmenopausal vasomotor symptoms
NCT03291067Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elismetrep in vasomotor symptoms, sponsored by Mitsubishi Tanabe Pharma Corporation. Started Oct 2017; status: completed.
02
Drugs
elismetrep
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT03291067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03291067.